Download FREE Sample
Table of Contents
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Monoclonal Antibody Therapeutics Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Rising prevalence of chronic and autoimmune diseases
- Advancements in the technologies related to drug engineering and development
- Increased funding and investments into research and development
- Approval of monoclonal antibody therapies
- Increased acceptance of personalized medicine
- Expanding applications of mAB therapy in various medical fields medicine
- Restraints
- High production and development costs
- Stringent regulatory requirements
- Patent expirations and biosimilar competition
- Complexities in formulation and stability
- Opportunities
- Rising demand in emerging markets
- Next-generation antibody platforms
- Expansion into rare and orphan diseases
- Combination therapies and ADCs
- Key Market Trends
- Adoption of artificial intelligence (AI) in drug discovery
- Rise of bispecific antibodies
- Biosimilar development and approvals
- Unmet Market Needs
- Industry Speaks
- Drivers
- Market Dynamics
- Global Monoclonal Antibody Therapeutics Market Size & Forecast (2023-2030), By Source, USD Million
- Introduction
- Human Source
- Humanized Source
- Chimeric Source
- Others
- Global Monoclonal Antibody Therapeutics Market Size & Forecast (2023-2030), By Application, USD Million
- Introduction
- Oncology
- Autoimmune Diseases
- Infectious Diseases
- Hematologic Diseases
- Ophthalmology
- Others
- Global Monoclonal Antibody Therapeutics Market Size & Forecast (2023-2030), By End User, USD Million
- Introduction
- Hospitals
- Long-term Care Facilities
- Others
- Global Monoclonal Antibody Therapeutics Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Monoclonal Antibody Therapeutics Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Canada
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- US
- Europe Monoclonal Antibody Therapeutics Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Germany
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- France
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Italy
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Spain
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Europe
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- UK
- Asia Pacific (APAC) Monoclonal Antibody Therapeutics Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Japan
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- India
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- China
- Latin America (LATAM) Monoclonal Antibody Therapeutics Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Middle East & Africa (MEA) Monoclonal Antibody Therapeutics Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Source (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Hoffmann-La Roche Ltd
- AbbVie Inc.
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc
- Bristol-Myers Squibb (BMS)
- Amgen Inc.
- Novartis AG
- Eli Lilly and Company
- Sanofi
- AstraZeneca
- Other Prominent Players
Note: *Indicative list
**For listed companies
